Skip to main content

Table 1 Basic characteristics assessment of included literatures

From: Traditional Chinese and western medicine for the prevention of deep venous thrombosis after lower extremity orthopedic surgery: a meta-analysis of randomized controlled trials

Study year Country Surgery site Experimental group Control group Prevention method Study quality
n Male/female Age n Male/female Age Experimental group Control group  
Bi CQ 2009 [12] China Fracture and arthroplasty 35 10\25 69.57 ± 9.84 35 7\28 66.71 ± 9.13 On the basis of the control group, Yiqi Poxue traditional Chinese medicine Low molecular weight heparin (LMWH) RCT
Chen CL 2014 [13] China Arthroplasty 48 18\30 64.5 ± 15.6 48 12\36 61.7 ± 12.5 On the basis of the control group, Taohong Siwu soup Rivaroxaban RCT
Chen T 2016 [14] China Fracture 45 24\21 60.6 ± 1.8 45 25\20 60.5 ±2.1 On the basis of the control group, topical with traditional Chinese medicine Low molecular weight heparin (LMWH), aspirin RCT
Ge XL 2007 [15] China Arthroplasty 30 66.8 30 66.8 On the basis of the control group, Ligustrazine hydrochloride Low molecular weight heparin (LMWH) RCT
He Y 2013 [16] China Arthroplasty 62 64 62 64 On the basis of the control group, Yiqi Huoxue Huayu soup Low molecular weight heparin (LMWH) RCT
Huang SX 2009 [17] China Fracture and arthroplasty 60 35\25 58.6 60 38\22 56.2 On the basis of the control group, Danshen injection liquid Low molecular weight heparin (LMWH) RCT
Huang XG 2010 [18] China Arthroplasty 31 11\20 58.46 32 9\23 55.72 On the basis of the control group, Gubu soup Low molecular weight heparin (LMWH) RCT
Jiang KW 2011 [19] China Arthroplasty 65 66.4 73 66.4 Chinese medicine decoction Low molecular weight heparin (LMWH) RCT
Li DF 2015 [20] China Fracture and arthroplasty 25 16\9 22–76 25 18\7 27–77 On the basis of the control group, Huoxue Tongmai soup Rivaroxaban RCT
Li JH 2015 [21] China fracture 44 72±17 41 68±18 Danggui Shaoyao powder Low molecular weight heparin (LMWH) RCT
Lin X 2010 [22] China Arthroplasty 40 25\15 78.15 ± 15.43 40 26\14 76.36 ± 14.37 Buyang Huanwu soup Aspirin RCT
Shao ZH 2016 [23] China Arthroplasty 45 24\21 67.4 ± 5.1 45 23\22 66.6 ± 4.8 On the basis of the control group, Danshen injection liquid, Taohong Siwu soup Rivaroxaban RCT
Shi M 2011 [24] China Arthroplasty 29 22\7 69.13 ± 7.89 34 23\11 67.49 ± 8.36 Chinese medicine decoction Low molecular weight heparin (LMWH) RCT
Wang XG 2017 [25] China Fracture and arthroplasty 34 15\19 62.6 ± 5.81 34 16\18 63.4 ± 3.17 On the basis of the control group, Tongmai Yiqi Chinese medicine decoction Low molecular weight heparin (LMWH) RCT
Xiao G 2015 [26] China Fracture 38 38 On the basis of the control group, Chinese medicine decoction Low molecular weight heparin (LMWH) RCT
Yuan SH 2009 [27] China Arthroplasty 28 16\12 66.4 26 16\10 64.5 On the basis of the control group, Shuxue Tongmai injection liquid Low molecular weight heparin (LMWH) RCT
Zhai JB 2016 [28] China Fracture and arthroplasty 38 18\20 64.5 ± 10.2 38 21\17 63.1 ± 10.8 On the basis of the control group, Chinese medicine decoction self-made Low molecular weight heparin (LMWH) RCT
Zhang FY 2009 [29] China Fracture and arthroplasty 45 34\11 60 42 30\12 56 On the basis of the control group, Danshen injection liquid Low molecular weight heparin (LMWH) RCT
Zhao Q 2017 [30] China Fracture 95 44\51 58.94 ± 7.02 95 47\48 58.96 ± 4.93 On the basis of the control group, Huoxue Zhuyu Tongluo soup Low molecular weight heparin (LMWH) RCT
Zhou ZQ 2010 [31] China Fracture and arthroplasty 73 44\29 15–85 109 57\52 15–85 Honghua injection liquid Low molecular weight heparin (LMWH) RCT